Risk factors for proteinuria in HIV-infected and -uninfected Hispanic drug users
- PMID: 18572293
- PMCID: PMC2585977
- DOI: 10.1053/j.ajkd.2008.04.016
Risk factors for proteinuria in HIV-infected and -uninfected Hispanic drug users
Abstract
Background: Proteinuria may be an early marker of chronic kidney disease in human immunodeficiency virus (HIV)-infected patients with coexisting chronic hepatitis and/or drug use. Minorities are at greater risk of chronic kidney disease. Data are limited about risk factors for proteinuria in Hispanic drug users with and without HIV infection.
Study design: A cross-sectional study.
Setting & participants: A community-recruited Hispanic cohort to study the role of drug use in HIV-associated malnutrition composed of 4 groups (106 HIV-infected drug users, 96 HIV-uninfected drug users, 38 HIV-infected non-drug users, and 47 healthy controls). Patients on renal replacement therapy were excluded.
Predictors: HIV infection, chronic hepatitis, history of hypertension or diabetes, and intravenous drug use (never, prior, or current).
Outcomes & measurements: The presence of proteinuria was defined as urine dipstick result of 1+ or greater. Multivariable logistic regression was used to identify independent risk factors for proteinuria.
Results: Of 287 patients with available data, 24 (8.4%) had proteinuria. In univariate analyses, those with HIV infection; prior, but not current, intravenous drug use; and a history of hypertension or diabetes were more likely to have proteinuria. In multivariate analyses, significant risk factors for proteinuria were HIV infection (odds ratio, 9.2; 95% confidence interval, 1.9 to 45.8; P = 0.007); prior, but not current, intravenous drug use (odds ratio, 4.7; 95% confidence interval, 1.4 to 15.3; P = 0.01); and history of hypertension or diabetes (odds ratio, 8.2; 95% confidence interval, 3.1 to 21.7; P < 0.001).
Limitations: The cross-sectional study design makes it difficult to establish the temporal relationship. The number of outcomes in relation to the number of predictors is small.
Conclusions: HIV and prior intravenous drug use, but not chronic hepatitis or current intravenous drug use, were independently associated with proteinuria in this Hispanic population. Longitudinal studies to assess the development of proteinuria and chronic kidney disease in this high-risk population are warranted.
Similar articles
-
HIV and proteinuria in an injection drug user population.Clin J Am Soc Nephrol. 2010 Oct;5(10):1836-43. doi: 10.2215/CJN.01030210. Epub 2010 Aug 12. Clin J Am Soc Nephrol. 2010. PMID: 20705967 Free PMC article.
-
Risk factors for ESRD in HIV-infected individuals: traditional and HIV-related factors.Am J Kidney Dis. 2012 May;59(5):628-35. doi: 10.1053/j.ajkd.2011.10.050. Epub 2011 Dec 28. Am J Kidney Dis. 2012. PMID: 22206742 Free PMC article.
-
Vitamin D deficiency and persistent proteinuria among HIV-infected and uninfected injection drug users.AIDS. 2012 Jan 28;26(3):295-302. doi: 10.1097/QAD.0b013e32834f33a2. AIDS. 2012. PMID: 22156964 Free PMC article.
-
Prevalence of low estimated glomerular filtration rate, proteinuria, and associated risk factors among HIV-infected black patients using Cockroft-Gault and modification of diet in renal disease study equations.J Acquir Immune Defic Syndr. 2012 Jan 1;59(1):59-64. doi: 10.1097/QAI.0b013e31823587b0. J Acquir Immune Defic Syndr. 2012. PMID: 21926635
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
Cited by
-
Race and other risk factors for incident proteinuria in a national cohort of HIV-infected veterans.J Acquir Immune Defic Syndr. 2014 Oct 1;67(2):145-52. doi: 10.1097/QAI.0000000000000285. J Acquir Immune Defic Syndr. 2014. PMID: 25072613 Free PMC article.
-
Predictors of end-stage renal disease in the urban poor.J Health Care Poor Underserved. 2013 Nov;24(4):1686-700. doi: 10.1353/hpu.2013.0189. J Health Care Poor Underserved. 2013. PMID: 24185164 Free PMC article.
-
Hepatitis C Virus Infection Increases the Risk of Developing Chronic Kidney Disease: A Systematic Review and Meta-Analysis.Dig Dis Sci. 2015 Dec;60(12):3801-13. doi: 10.1007/s10620-015-3801-y. Epub 2015 Jul 21. Dig Dis Sci. 2015. PMID: 26195311
-
HIV and proteinuria in an injection drug user population.Clin J Am Soc Nephrol. 2010 Oct;5(10):1836-43. doi: 10.2215/CJN.01030210. Epub 2010 Aug 12. Clin J Am Soc Nephrol. 2010. PMID: 20705967 Free PMC article.
References
-
- Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV-infected patients: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. 2005;40:1559–1585. - PubMed
-
- Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. AIDS. 2004;18:541–546. - PubMed
-
- Bruggeman LA, Ross MD, Tanji N, et al. Renal epithelium is a previously unrecognized site of HIV-1 infection. J Am Soc Nephrol. 2000;11:2079–2087. - PubMed
-
- Marras D, Bruggeman LA, Gao F, et al. Replication and compartmentalization of HIV-1 in kidney epithelium of patients with HIV-associated nephropathy. Nat Med. 2002;8:522–526. - PubMed
-
- Green DF, Resnick L, Bourgoignie JJ. HIV infects glomerular endothelial and mesangial but not epithelial cells in vitro. Kidney Int. 1992;41:956–960. - PubMed
Publication types
MeSH terms
Grants and funding
- KL2 RR025751/RR/NCRR NIH HHS/United States
- DA11598/DA/NIDA NIH HHS/United States
- R01 DA014501/DA/NIDA NIH HHS/United States
- K23 DK081017/DK/NIDDK NIH HHS/United States
- P01 DK045734/DK/NIDDK NIH HHS/United States
- M01 RR000054/RR/NCRR NIH HHS/United States
- T32 AI007329/AI/NIAID NIH HHS/United States
- U01 DK053869/DK/NIDDK NIH HHS/United States
- DK45734-07/DK/NIDDK NIH HHS/United States
- M01-RR00054/RR/NCRR NIH HHS/United States
- 5-P30 DA013868-02/DA/NIDA NIH HHS/United States
- T32 AI007389/AI/NIAID NIH HHS/United States
- P30 DA013868/DA/NIDA NIH HHS/United States
- R01 DA011598/DA/NIDA NIH HHS/United States
- 1-P308142853/PHS HHS/United States
- DA14501/DA/NIDA NIH HHS/United States
- UL1 RR025752/RR/NCRR NIH HHS/United States
- DK U01 DK053869/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical